{
  "id": 1564,
  "text": "Table 32.Original studies presenting survival and response rates data according to NACT regimens administered in patients with LACC <html><body><table><tr><td>Authorreference</td><td>Year</td><td>N</td><td></td><td>Response</td><td>Survival (%)</td><td></td></tr><tr><td>Abou-Taleb et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Table 32.Original studies presenting survival and response rates data according to NACT regimens administered in patients with LACC <html><body><table><tr><td>Authorreference</td><td>Year</td><td>N</td><td></td><td>Response</td><td>Survival (%)</td><td></td></tr><tr><td>Abou-Taleb et al.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "新辅助化疗（NACT）在高级别局部晚期宫颈癌（LACC）患者中使用时，其生存率和响应率根据不同的化疗方案和研究报告进行了分类。研究人员通过各种方案评估患者的治疗响应，包括部分缓解、完全缓解和疾病稳定等指标。此外，这些研究中还报告了患者的长期生存率数据，一般以5年或更长时间的生存率百分比进行展示。这些数据帮助临床医生根据具体情况选择最适合患者的治疗方案，以期提高响应率和生存率。详细的结果和分类通常会反映在相关的医学文献中，并随着新研究的开展而不断更新。",
  "query": "针对高级别局部晚期宫颈癌（LACC）的患者，使用新辅助化疗（NACT）方案后，其生存率和响应率的数据是如何分类和报告的？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 针对高级别局部晚期宫颈癌（LACC）的患者，使用新辅助化疗（NACT）方案后，其生存率和响应率的数据是如何分类和报告的？\n\n<reference text>: Table 32.Original studies presenting survival and response rates data according to NACT regimens administered in patients with LACC <html><body><table><tr><td>Authorreference</td><td>Year</td><td>N</td><td></td><td>Response</td><td>Survival (%)</td><td></td></tr><tr><td>Abou-Taleb et al.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "新辅助化疗（NACT）在高级别局部晚期宫颈癌（LACC）患者中使用时，其生存率和响应率根据不同的化疗方案和研究报告进行了分类。研究人员通过各种方案评估患者的治疗响应，包括部分缓解、完全缓解和疾病稳定等指标。此外，这些研究中还报告了患者的长期生存率数据，一般以5年或更长时间的生存率百分比进行展示。这些数据帮助临床医生根据具体情况选择最适合患者的治疗方案，以期提高响应率和生存率。详细的结果和分类通常会反映在相关的医学文献中，并随着新研究的开展而不断更新。"
}